Chronic Fatigue Syndrome Naming

NewsGuard 100/100 Score

The medical term used for chronic fatigue syndrome is myalgic encephalomyelitis. This term can be divided into “myo” for muscle, “algia” for pain and “encephalomyelitis” meaning inflammation of the brain and spinal cord.

The naming and classification of chronic fatigue syndrome in the medical literature has presented many challenges over the years. This is due to the fact that the exact cause of the disease is not known, the symptoms vary between sufferers and it is difficult to diagnose with confidence. There is a lack of consensus among experts over how the condition should be classified, with some individuals believing the central nervous system is involved and others thinking the underlying pathology is linked to infection, heart disease or an immune system disorder. In some disciplines, the syndrome is also considered to be a psychiatric disorder rather than a physical one.

The name given to chronic fatigue syndrome has varied over the years and by country, with examples including:

  • Akureyri disease
  • Benign myalgic encephalomyelitis
  • Chronic fatigue immune dysfunction syndrome
  • Chronic infectious mononucleosis or chronic Epstein Barr virus disease
  • Epidemic myalgic encephalomyelitis
  • Epidemic neuromyasthenia
  • Iceland disease
  • Post-viral fatigue syndrome (PVFS)
  • Raphe nucleus encephalopathy
  • Royal Free disease
  • Tapanui flu
  • Yuppie flu

Some patients prefer to call the condition myalgic encephalomyelitis or ME rather than chronic fatigue syndrome. However, in 1999, a review from the Royal Colleges of Physicians, Psychiatrists, and General Practitioners suggested that there was not sufficient evidence of a disease involving the muscles and central nervous system to justify the term myalgic encephalomyelitis. This was severely criticised and in 2002, a commentary in The Lancet noted that a report by the CFS/ME Working Group stated that since there was a lack of consensus over which term should be used, both the terms could be used.

Further Reading

Last Updated: Jul 14, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 14). Chronic Fatigue Syndrome Naming. News-Medical. Retrieved on April 18, 2024 from https://www.news-medical.net/health/Chronic-Fatigue-Syndrome-Naming.aspx.

  • MLA

    Mandal, Ananya. "Chronic Fatigue Syndrome Naming". News-Medical. 18 April 2024. <https://www.news-medical.net/health/Chronic-Fatigue-Syndrome-Naming.aspx>.

  • Chicago

    Mandal, Ananya. "Chronic Fatigue Syndrome Naming". News-Medical. https://www.news-medical.net/health/Chronic-Fatigue-Syndrome-Naming.aspx. (accessed April 18, 2024).

  • Harvard

    Mandal, Ananya. 2023. Chronic Fatigue Syndrome Naming. News-Medical, viewed 18 April 2024, https://www.news-medical.net/health/Chronic-Fatigue-Syndrome-Naming.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Long COVID's biological blueprint: new study offers promising insights